Bactiguard’s infection prevention central venous catheter, BIP CVC, with Bactiguard coating reduces microbial adhesion, which decreases the risk of biofilm formation and infection.
Catheter related bloodstream infection is one of the most common healthcare associated infections1 and at the same time one of the most expensive and fatal complications associated with central venous catheters. The catheter surface attracts microbes, which colonize it and may develop a biofilm leading to infection.
The unique Bactiguard technology reduces microbial adhesion on the catheter
The Bactiguard technology (Bactiguard Infection Protection) is based on a very thin noble metal alloy coating, firmly attached to the catheter surface. When in contact with fluids (blood), the noble metals create a galvanic effect which reduces microbial adhesion. This means that less bacteria adhere to the catheter surface, which reduces the risk of biofilm formation leading to infection.
Safe and tissue friendly
Bactiguard’s coating is firmly attached to the catheter, which makes the technology both safe and tissue friendly as opposed to traditional coating technologies, that often depend on the release of substances that kill the bacteria, e.g. higher concentrations of silver ions, chlorhexidine or antibiotics.
The product is well proven, more than 100,000 patients have been included in clinical trials and over 200 million catheters have been used without any reported side adverse events related to the coating.
Excellent blood combability
Thrombotic complications are common and lead to obstruction of blood flow and catheter dysfunction. The catheter may need to be exchanged and the risk of infection increases, leading to increased costs of care. Catheter-related thrombosis leads to increased morbidity and may increase mortality due to embolic events.2
The Bactiguard coating has shown very good blood compatibility. In addition, clinical data show that there is no increased risk of thrombosis or hemolysis when using products with Bactiguard’s technology.3
BIP CVC provides cost savings
BIP CVC is associated with lower length of hospital stay costs, lower treatment costs and improved patient quality of life.4
The BIP CVC is used for administration of drugs and intravenous solutions, sample blood and for blood pressure monitoring. It is made of polyurethane, coated with the Bactiguard coating and approved for use up to 30 days. BIP CVC is available in many different sizes, lengths and number of lumens (1-4 lumens), as well as with a straight needle, Y-valve needle or Raulerson syringe.
1. Klevens RM et al. Estimating healthcare associated infections and deaths in U.S. hospitals, 2002 Public Health Rep. 2007 Mar-Apr;122(2):160–6.
2. Wall et al. Catheter-related thrombosis: A practical aproach, Journal of the Intensive Care Society 2016, Vol. 17(2) 160–167
3. Harter et al, Cancer. 94 (1):245–251 (2002).
4. Saint S. et al. Arch Intern Med. 2000;160:2670–2675.